{"ticker": {"uuid": "fcb49788-2486-40a0-adc0-252e820a9044", "symbol": "NNO2", "name": "Novo Nordisk A/S", "exchange": "VIE", "country": "AT", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Why is Novo Nordisk stock up today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNWjl1RWFWV0RNSVlnYXg3aDdMVWRHNG1yZU1ZR2tPQjNLUzRoN01pS0txOUV2NHgybFdXRHFGZ25ROVRKNGVJbDlsWFZKcWZmMExqNGNZVmM0OXBEOTItdzJrTEVkazhUWGh3X0lNanB5RkwtdS1NdEdzbkhBeVdITkREWGR4enRyZ2d4clpVWlNnZHpCZ3MzcExpZw?oc=5", "source_name": "Traders Union", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NVO) Stock Jumps 7% as Oral Wegovy Lands in the UK", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNTnlDRHdUR0tnYUljX2NnNFZVZ21vOTJ5b1ZZby1LUFVHMkkwQ2paSm9tUFYyZEJYbjZGTGxGZExGMDhJTGF3SGZHZmZwQU9OU21qbVBIdHV3Z3NqbnVGSkhrb2gxMGl5ZldkYTVQZzFNc3duYm8yTnNya2ZIVmpzb0tZaGFvUWRWSHFiM1lKOA?oc=5", "source_name": "CoinCentral", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk shares jump as stock buying pressure builds", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNNHdTNUtlcVJtNE10N3NwTWdlNXNFSWY4TkhrSnhJOEdIaGNhcDFRemp1RHlKZ2xqSGZVQlBXMXNIbUExUmd3TmF0N2IxY29LTEx3MlB1SmNfMHFDYjVubHRzYzV4ZjNFdnlWeEdub213anNfVGE3R2psd1VyMGozN09iN3BnLWI4S2Rfb3BDQmJvbkJ2akh6SnNHSQ?oc=5", "source_name": "Traders Union", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oral Wegovy regulatory filing in China supports Novo Nordisk stock at current level", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNWmJaNUhOUEtCUjdvUjVuMjJDMTM2UDV4U3BhRDRHOEVvS0NNSjFvNVVoTTVLeWtEVndUNTBtVVdOR25RVk9OU1lVbnN6ZmhfdUR4MVEyYm5sRm5kMHFVd1NpRDdabTV6dmNaMEZfT0c4R0NILTR3bzVlejhPbzFsZEdTbEF0V0t2OC15dzhSWTVPdXhMMDc0?oc=5", "source_name": "Traders Union", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: A Fallen Leader Trading At Fair Value, Not A Bargain (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQeGJOZDdTMGFXYUVxblRqZkF1VXRjcnFQSTVlRG5oX2NabHdBOUVoVm1fNnZsRjQwdFQyblpxcTdoYmFjaU9FdVBOMHdsRm9sUGhDdmFBWVhFelJnc0prQkpGaHZTY2tLQ21kT0lHaEMyTVpadHREbm5lN1ZKSi0yQ2VzRzdGajF3RmFEWDVyMzZnYXVBS1JQbF8tTjNYUUlFNnRVaHZ1MFE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Novo Nordisk stock down today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQcHlSazV1XzVVbC1FSFhsbmQtS09mSFlTUzNUZFRlLS04bTN1UXdVdlozQ1Jpeko5Z0hJeGViZUpDZ1pSMzFWM29ZbExOUUpkRmlzZ0NrcFVpaVNZYWhGbFVydjBWSktlVl8yU0tacFdDZ0FReFQ4NDhGb21DZWJiNklneFBZOC1RYzMtWEI3SGtvVzVWaEd2WVdxSnI?oc=5", "source_name": "Traders Union", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NVO) Stock Gets a Boost as Wegovy Pill Clears EU Review", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNZjI3MGNtYjROQ1FlZmd4eEZyNVkxcGR0TXZZV0JueTVjYTJxNHhvTk9WZF9od2ZuNlJoRjE2dXdSNzJvLWJsWmxocERoWTBoUEJtUU43NDNvRVJjNG1ZUnFvM2puX1RmcVYtZnI1YVRXa3NsMmtPc2kxSWd3LTJoWnFzZWdyOXA1OHJ4bnB6WUZ5d19Hc2RR?oc=5", "source_name": "CoinCentral", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amycretin trial success drives Novo Nordisk stock to a 1.81% rise", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPcEl1SDloQWZRLVRiY2xKQnNJdTU1UFl6WTd5M196dUp6cm9TRE5SdmF1SjVlaldhbHlQek5lREFTT2JSZVhzYUZnTUEzMVp6ell2ZzFRdFRIWVQyQkdYTmVMSUhHc3dURnEzT3NrLUE0OXMtUE5uMlhCT1JwLVA3b2FEVG5adnpIN3NNajhFbzIxMXJnbTJF?oc=5", "source_name": "Traders Union", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk stock trades down as price remains far below long-term average", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQNzN6cVFRMHRjb1lqZm1LejVKQkZUZmtEUjlLdkc4Tk9YcHlWUmlJM2JoVElvXzJLcndIRDJRV2RhcENaSmZlMW5DS1RIckl5dmh5Y1V1RzNzOW9Ha2VsdEt3Nzl0OW1oQ2swQk5JTjdUV1c1Ri0yd2R3UHNyalRsVEhYVDB1SXZlTGhtMXZaUjlYOFZlQ2I0X0Z5QUc?oc=5", "source_name": "Traders Union", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "-2.48% for Novo Nordisk stock as regulatory discussions heat up in US Congress", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQUHU2Vmx1OHNQdF9mblpvVEhhTkl0N1lJT0xpSnVmeWl6Mm41SVViZEJsc2FEOXRGUTc1ZjNQbmtCNC1ETUdHMm1yekNTNlJ1bXBkYVd1YzRtc2Y2UmNmZElqakVZN1ZBVndzc3NpQVJXTDhrWGg0UlQ3NHdPN0twMDgyd3Z2WGRnTGgzUng4MTFuNkRCdjFSSy00N08?oc=5", "source_name": "Traders Union", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2026-2030 (Jan 2026)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQNEZ6MWVaRXMwM2ZLSkVzcFRUVGtUajRubm5wVGxrdF9qTkNpNC10ZDJDb18wb1dEb1lncXhGYmpHNHFpNmV3N2s0OWxsdkVCRVltLTNBTm1YWFJGM2hJOW5qSzRiS3ZrVlJQZHRxZWY0OUZHSXVxb3N1S0JmRnVHa2VRODVxTnZoVEVtOUIxWElZdTN3Q3hMbzJTalIxWFR2UnJYU0hCcw?oc=5", "source_name": "24/7 Wall St.", "published_at": "2026-01-21T08:00:00+00:00", "published_display": "21 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NVO) Stock Jumps as Wegovy Pill Launches in United States", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQM3NUdVZIMXkyQUpXODNEMU1WT0IwQms4TDk3aUJCYjVhTUJlQzZ0UE9GTGxhY203REw2aklvRnY3UGd1UWtxS2NKazd1V2ItM0JVdTFnazFyTklOOWdlcjk1ZnI3dnFEbVV2cVFaaE84bXFjLWNfcWlTQjI1UE9Sbm5XVFUzMlBRalA0WTJuenBIT1p5bDVRLVZB?oc=5", "source_name": "CoinCentral", "published_at": "2026-01-06T08:00:00+00:00", "published_display": "06 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk REACH Study Shows Ozempic Reduces Cardiovascular Risk by 23% Compared With Dulaglutide", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPSllQaGQyQlhTbWxyV29WUVZiZWVWSU03V1dPOEdqMHN5R3hpeGtpTElJZ2NkU2hYM3ktS20ySl9Yd09fSUQxNkpDV1RqSzFkZGgydUF1Q3FwTDNHY1NJRHhlUllPRmg5M25DRzkyRllKTWJuUFNjWVd6VlBDZklwX3pNMUdLZ3JkUjUyOUczMUxYSFBJVllCd0FBOUZ5RGl4NzRYNEIxM244bzFtQ1BGMUZFVQ?oc=5", "source_name": "Applied Clinical Trials Online", "published_at": "2025-09-19T07:00:00+00:00", "published_display": "19 Sep 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk presents phase 3 data for next-generation", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwJBVV95cUxPbWJ1eEZQNHRhQ2s5V3ZWZS1OQVpzeFVYcGNPaVZDVG5hY2U2QjlyOXdHaWIzNzg1V0VLMFJQN2NORm5fLXcyRWVaN3o0a1I5LTBwWHhvUThpZDl1Q1BFbzV4WDNuWlcxUDVhZXdXNTdNaE1LdTNjZVVlYUZiTFpLdDZENzUxa2UxU2UxX29LeXNKQW1KN2V4NzNYRFktQ2VzOUpQM1NoQnRBdTc2dVBNSU5TOHpSdVA1NUoxMVBMTURMeXJZeV9mMkd4MHl1QXRvX3BwRkpXSGVfMzAyS1lxUlpISnNwdmlIa2huNG9EWUM0R3RMU3dZbFZIanQ3NlFVTGF6WG54eXBsUUZ0d1h4Tk42RGF1dmpObDJ1NVNYUy10YngybmFYeTBIZw?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-09-16T07:00:00+00:00", "published_display": "16 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "People taking Novo Nordisk\u2019s Wegovy\u00ae experienced reduced food noise and boosted mental well-being", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_AFBVV95cUxQZkdsUWg2eWNCQURTc04wbjNNc0FIemdyTmZZR0pBWkd3UU5zZWdJSm5lZy0wcklEUlpmaGViUmdtR09Fal9MUGpwVUdOYm50T0V3V2x4U18tM3NrUngzR3gyRkdaZG5KYUNXOEhwcEFJU0Jvb2h0VGJGQ2FWQ2FGVDNCU0JrRjBsVkZwTGdkX19XQnZfOTQyd3dMSm5nTmNlaG5rU09sNDZ5bTMxOHhZSjRVUzlYaUFFVFctSDg3LU9Ic3dOaXRBc19ISGZVUV9yX25ZTXEtYWpxbUFwdFI3VTAwOGNtaFYteFhaUEJKdXozTmJKazJPMTktd3g?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-09-15T07:00:00+00:00", "published_display": "15 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk owner buys majority stake in Austrian life science tools company", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPa0VqY1hFLWRybVpDbm0wLWtDTEVQc1RjTzBCMENqOUFFY0I3dWp1dnUyU3ExTjVsVTFvT0dpVjVyZ1ZnM3d1MEFRUmo0QkNCY1oxaXNUZVlvX05icXJtSDhEZWFVckgzb3dTU01kOElBU1dxUk5CVHVHcWxvc2Utam9PaUtMNTNiNERuWTRtRW8zd0s1aDZoanNqRG9wN3ltQ2JSX2lZaVRRRWMtVXlTN0xxTDlTOFBZa3Bud1JRbzg0Zw?oc=5", "source_name": "Reuters", "published_at": "2024-05-15T07:00:00+00:00", "published_display": "15 May 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NOVO-NORDISK AS stock price at wienerborse.at/en", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxQQlV1YWVKTndpM2pacHllM0FnZjBaUmV5X2VKOGlCNVM4SW5IbkdiMWRsSXM3WXVGY2JZU1FGVFhBNXZJRGFpV3h6YWFzaDJ1MGgtV2lkR0QxbktOazNPU3NYbHgzMmhjLTRVQzRvLTBuYkwzY0RfNWFJMU1LSmwwR1RHWlQ3QQ?oc=5", "source_name": "Wiener B\u00f6rse", "published_at": "2023-09-13T09:28:53+00:00", "published_display": "13 Sep 2023 09:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Why is Novo Nordisk stock up today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNWjl1RWFWV0RNSVlnYXg3aDdMVWRHNG1yZU1ZR2tPQjNLUzRoN01pS0txOUV2NHgybFdXRHFGZ25ROVRKNGVJbDlsWFZKcWZmMExqNGNZVmM0OXBEOTItdzJrTEVkazhUWGh3X0lNanB5RkwtdS1NdEdzbkhBeVdITkREWGR4enRyZ2d4clpVWlNnZHpCZ3MzcExpZw?oc=5", "source_name": "Traders Union", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NVO) Stock Jumps 7% as Oral Wegovy Lands in the UK", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNTnlDRHdUR0tnYUljX2NnNFZVZ21vOTJ5b1ZZby1LUFVHMkkwQ2paSm9tUFYyZEJYbjZGTGxGZExGMDhJTGF3SGZHZmZwQU9OU21qbVBIdHV3Z3NqbnVGSkhrb2gxMGl5ZldkYTVQZzFNc3duYm8yTnNya2ZIVmpzb0tZaGFvUWRWSHFiM1lKOA?oc=5", "source_name": "CoinCentral", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk shares jump as stock buying pressure builds", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNNHdTNUtlcVJtNE10N3NwTWdlNXNFSWY4TkhrSnhJOEdIaGNhcDFRemp1RHlKZ2xqSGZVQlBXMXNIbUExUmd3TmF0N2IxY29LTEx3MlB1SmNfMHFDYjVubHRzYzV4ZjNFdnlWeEdub213anNfVGE3R2psd1VyMGozN09iN3BnLWI4S2Rfb3BDQmJvbkJ2akh6SnNHSQ?oc=5", "source_name": "Traders Union", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oral Wegovy regulatory filing in China supports Novo Nordisk stock at current level", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNWmJaNUhOUEtCUjdvUjVuMjJDMTM2UDV4U3BhRDRHOEVvS0NNSjFvNVVoTTVLeWtEVndUNTBtVVdOR25RVk9OU1lVbnN6ZmhfdUR4MVEyYm5sRm5kMHFVd1NpRDdabTV6dmNaMEZfT0c4R0NILTR3bzVlejhPbzFsZEdTbEF0V0t2OC15dzhSWTVPdXhMMDc0?oc=5", "source_name": "Traders Union", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: A Fallen Leader Trading At Fair Value, Not A Bargain (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQeGJOZDdTMGFXYUVxblRqZkF1VXRjcnFQSTVlRG5oX2NabHdBOUVoVm1fNnZsRjQwdFQyblpxcTdoYmFjaU9FdVBOMHdsRm9sUGhDdmFBWVhFelJnc0prQkpGaHZTY2tLQ21kT0lHaEMyTVpadHREbm5lN1ZKSi0yQ2VzRzdGajF3RmFEWDVyMzZnYXVBS1JQbF8tTjNYUUlFNnRVaHZ1MFE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Novo Nordisk stock down today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQcHlSazV1XzVVbC1FSFhsbmQtS09mSFlTUzNUZFRlLS04bTN1UXdVdlozQ1Jpeko5Z0hJeGViZUpDZ1pSMzFWM29ZbExOUUpkRmlzZ0NrcFVpaVNZYWhGbFVydjBWSktlVl8yU0tacFdDZ0FReFQ4NDhGb21DZWJiNklneFBZOC1RYzMtWEI3SGtvVzVWaEd2WVdxSnI?oc=5", "source_name": "Traders Union", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NVO) Stock Gets a Boost as Wegovy Pill Clears EU Review", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNZjI3MGNtYjROQ1FlZmd4eEZyNVkxcGR0TXZZV0JueTVjYTJxNHhvTk9WZF9od2ZuNlJoRjE2dXdSNzJvLWJsWmxocERoWTBoUEJtUU43NDNvRVJjNG1ZUnFvM2puX1RmcVYtZnI1YVRXa3NsMmtPc2kxSWd3LTJoWnFzZWdyOXA1OHJ4bnB6WUZ5d19Hc2RR?oc=5", "source_name": "CoinCentral", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amycretin trial success drives Novo Nordisk stock to a 1.81% rise", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPcEl1SDloQWZRLVRiY2xKQnNJdTU1UFl6WTd5M196dUp6cm9TRE5SdmF1SjVlaldhbHlQek5lREFTT2JSZVhzYUZnTUEzMVp6ell2ZzFRdFRIWVQyQkdYTmVMSUhHc3dURnEzT3NrLUE0OXMtUE5uMlhCT1JwLVA3b2FEVG5adnpIN3NNajhFbzIxMXJnbTJF?oc=5", "source_name": "Traders Union", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk stock trades down as price remains far below long-term average", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQNzN6cVFRMHRjb1lqZm1LejVKQkZUZmtEUjlLdkc4Tk9YcHlWUmlJM2JoVElvXzJLcndIRDJRV2RhcENaSmZlMW5DS1RIckl5dmh5Y1V1RzNzOW9Ha2VsdEt3Nzl0OW1oQ2swQk5JTjdUV1c1Ri0yd2R3UHNyalRsVEhYVDB1SXZlTGhtMXZaUjlYOFZlQ2I0X0Z5QUc?oc=5", "source_name": "Traders Union", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "-2.48% for Novo Nordisk stock as regulatory discussions heat up in US Congress", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQUHU2Vmx1OHNQdF9mblpvVEhhTkl0N1lJT0xpSnVmeWl6Mm41SVViZEJsc2FEOXRGUTc1ZjNQbmtCNC1ETUdHMm1yekNTNlJ1bXBkYVd1YzRtc2Y2UmNmZElqakVZN1ZBVndzc3NpQVJXTDhrWGg0UlQ3NHdPN0twMDgyd3Z2WGRnTGgzUng4MTFuNkRCdjFSSy00N08?oc=5", "source_name": "Traders Union", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2026-2030 (Jan 2026)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQNEZ6MWVaRXMwM2ZLSkVzcFRUVGtUajRubm5wVGxrdF9qTkNpNC10ZDJDb18wb1dEb1lncXhGYmpHNHFpNmV3N2s0OWxsdkVCRVltLTNBTm1YWFJGM2hJOW5qSzRiS3ZrVlJQZHRxZWY0OUZHSXVxb3N1S0JmRnVHa2VRODVxTnZoVEVtOUIxWElZdTN3Q3hMbzJTalIxWFR2UnJYU0hCcw?oc=5", "source_name": "24/7 Wall St.", "published_at": "2026-01-21T08:00:00+00:00", "published_display": "21 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NVO) Stock Jumps as Wegovy Pill Launches in United States", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQM3NUdVZIMXkyQUpXODNEMU1WT0IwQms4TDk3aUJCYjVhTUJlQzZ0UE9GTGxhY203REw2aklvRnY3UGd1UWtxS2NKazd1V2ItM0JVdTFnazFyTklOOWdlcjk1ZnI3dnFEbVV2cVFaaE84bXFjLWNfcWlTQjI1UE9Sbm5XVFUzMlBRalA0WTJuenBIT1p5bDVRLVZB?oc=5", "source_name": "CoinCentral", "published_at": "2026-01-06T08:00:00+00:00", "published_display": "06 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk REACH Study Shows Ozempic Reduces Cardiovascular Risk by 23% Compared With Dulaglutide", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPSllQaGQyQlhTbWxyV29WUVZiZWVWSU03V1dPOEdqMHN5R3hpeGtpTElJZ2NkU2hYM3ktS20ySl9Yd09fSUQxNkpDV1RqSzFkZGgydUF1Q3FwTDNHY1NJRHhlUllPRmg5M25DRzkyRllKTWJuUFNjWVd6VlBDZklwX3pNMUdLZ3JkUjUyOUczMUxYSFBJVllCd0FBOUZ5RGl4NzRYNEIxM244bzFtQ1BGMUZFVQ?oc=5", "source_name": "Applied Clinical Trials Online", "published_at": "2025-09-19T07:00:00+00:00", "published_display": "19 Sep 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk presents phase 3 data for next-generation", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwJBVV95cUxPbWJ1eEZQNHRhQ2s5V3ZWZS1OQVpzeFVYcGNPaVZDVG5hY2U2QjlyOXdHaWIzNzg1V0VLMFJQN2NORm5fLXcyRWVaN3o0a1I5LTBwWHhvUThpZDl1Q1BFbzV4WDNuWlcxUDVhZXdXNTdNaE1LdTNjZVVlYUZiTFpLdDZENzUxa2UxU2UxX29LeXNKQW1KN2V4NzNYRFktQ2VzOUpQM1NoQnRBdTc2dVBNSU5TOHpSdVA1NUoxMVBMTURMeXJZeV9mMkd4MHl1QXRvX3BwRkpXSGVfMzAyS1lxUlpISnNwdmlIa2huNG9EWUM0R3RMU3dZbFZIanQ3NlFVTGF6WG54eXBsUUZ0d1h4Tk42RGF1dmpObDJ1NVNYUy10YngybmFYeTBIZw?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-09-16T07:00:00+00:00", "published_display": "16 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "People taking Novo Nordisk\u2019s Wegovy\u00ae experienced reduced food noise and boosted mental well-being", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_AFBVV95cUxQZkdsUWg2eWNCQURTc04wbjNNc0FIemdyTmZZR0pBWkd3UU5zZWdJSm5lZy0wcklEUlpmaGViUmdtR09Fal9MUGpwVUdOYm50T0V3V2x4U18tM3NrUngzR3gyRkdaZG5KYUNXOEhwcEFJU0Jvb2h0VGJGQ2FWQ2FGVDNCU0JrRjBsVkZwTGdkX19XQnZfOTQyd3dMSm5nTmNlaG5rU09sNDZ5bTMxOHhZSjRVUzlYaUFFVFctSDg3LU9Ic3dOaXRBc19ISGZVUV9yX25ZTXEtYWpxbUFwdFI3VTAwOGNtaFYteFhaUEJKdXozTmJKazJPMTktd3g?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-09-15T07:00:00+00:00", "published_display": "15 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk owner buys majority stake in Austrian life science tools company", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPa0VqY1hFLWRybVpDbm0wLWtDTEVQc1RjTzBCMENqOUFFY0I3dWp1dnUyU3ExTjVsVTFvT0dpVjVyZ1ZnM3d1MEFRUmo0QkNCY1oxaXNUZVlvX05icXJtSDhEZWFVckgzb3dTU01kOElBU1dxUk5CVHVHcWxvc2Utam9PaUtMNTNiNERuWTRtRW8zd0s1aDZoanNqRG9wN3ltQ2JSX2lZaVRRRWMtVXlTN0xxTDlTOFBZa3Bud1JRbzg0Zw?oc=5", "source_name": "Reuters", "published_at": "2024-05-15T07:00:00+00:00", "published_display": "15 May 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NOVO-NORDISK AS stock price at wienerborse.at/en", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxQQlV1YWVKTndpM2pacHllM0FnZjBaUmV5X2VKOGlCNVM4SW5IbkdiMWRsSXM3WXVGY2JZU1FGVFhBNXZJRGFpV3h6YWFzaDJ1MGgtV2lkR0QxbktOazNPU3NYbHgzMmhjLTRVQzRvLTBuYkwzY0RfNWFJMU1LSmwwR1RHWlQ3QQ?oc=5", "source_name": "Wiener B\u00f6rse", "published_at": "2023-09-13T09:28:53+00:00", "published_display": "13 Sep 2023 09:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 69, "total_relevant": 17, "sentiment_summary": {"positive": 0, "negative": 1, "neutral": 16, "score": 49, "total": 17, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 86, "events": [{"event": "general", "label": "Market update", "weight": 7.5, "count": 13}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.9, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 43.21, "latest_week": "2026-07-10", "one_week_move": -1.1, "four_week_move": 12.8, "twelve_week_move": 20.6, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.573313, "market_dynamics_buy_signal": false, "relative_strength": 1.862276, "fair_value_gap": -12.0, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "positive", "expectation_probability": 61.1614, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.1% over one week, +12.8% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Traders Union", "count": 7}, {"label": "CoinCentral", "count": 3}, {"label": "GlobeNewswire", "count": 2}, {"label": "Seeking Alpha", "count": 1}, {"label": "24/7 Wall St.", "count": 1}, {"label": "Applied Clinical Trials Online", "count": 1}, {"label": "Reuters", "count": 1}, {"label": "Wiener B\u00f6rse", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 17}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 13}, {"label": "Regulatory and legal", "count": 2}, {"label": "Guidance", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "49/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "86/100 classification confidence."}, {"label": "Company focus", "value": "17", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-1.1% over one week, +12.8% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Why is Novo Nordisk stock up today?"}], "updated_at": "2026-07-18T03:14:23.030820+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}